Experts in treating prostate cancer highlight recent clinical data and discuss practical implications for patient care.
EP. 1: Castration Resistance Monitoring in Prostrate Cancer
EP. 2: Bone Health While Receiving ADT For Prostate Cancer
EP. 3: Cardiovascular Risk Related to ADT Therapy in Prostate Cancer
EP. 4: Oral LHRH Treatment for Prostate Cancer
EP. 5: Key Data for the Treatment of mCSPC
EP. 6: Androgen Receptor Blocker Use in mCSPC
EP. 7: Identifying Appropriate Therapy for Patients in Prostate Cancer
EP. 8: Clinical Trial Data for the Treatment of nmCRPC
EP. 9: The Importance of Treating nmCRPC
EP. 10: The Importance of Scans, NGS, and Imaging in nmCRPC
EP. 11: Treating Oligometastatic Prostate Cancer
EP. 12: The Current and Emerging Treatment Landscape of mCRPC
EP. 13: Germline and Somatic Testing in mCRPC
Irreversible electroporation with NanoKnife found safe, effective for prostate tissue ablation
Water vapor therapy demonstrates superior outcomes vs pharmaceutical therapy for BPH
Darolutamide plus ADT approved in EU for mHSPC
Mitomycin intravesical solution demonstrates long-term durability in LG-IR-NMIBC